NO144455C - Fremgangsmaate ved fremstilling av terapeutisk aktive nye piperidinderivater. - Google Patents
Fremgangsmaate ved fremstilling av terapeutisk aktive nye piperidinderivater.Info
- Publication number
- NO144455C NO144455C NO750698A NO750698A NO144455C NO 144455 C NO144455 C NO 144455C NO 750698 A NO750698 A NO 750698A NO 750698 A NO750698 A NO 750698A NO 144455 C NO144455 C NO 144455C
- Authority
- NO
- Norway
- Prior art keywords
- procedure
- preparation
- therapeutic active
- active new
- piperide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
- C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US05/447,926 US3946022A (en) | 1974-03-04 | 1974-03-04 | Piperidine derivatives |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO750698L NO750698L (tr) | 1975-09-05 |
| NO144455B NO144455B (no) | 1981-05-25 |
| NO144455C true NO144455C (no) | 1981-09-02 |
Family
ID=23778297
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO750698A NO144455C (no) | 1974-03-04 | 1975-03-03 | Fremgangsmaate ved fremstilling av terapeutisk aktive nye piperidinderivater. |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US3946022A (tr) |
| JP (1) | JPS50117780A (tr) |
| BE (1) | BE826012A (tr) |
| CA (1) | CA1053678A (tr) |
| CH (1) | CH610888A5 (tr) |
| DE (1) | DE2506770A1 (tr) |
| DK (2) | DK84375A (tr) |
| ES (1) | ES435246A1 (tr) |
| FR (1) | FR2262986B1 (tr) |
| GB (1) | GB1442118A (tr) |
| IE (1) | IE40598B1 (tr) |
| IL (1) | IL46613A (tr) |
| NL (1) | NL7502157A (tr) |
| NO (1) | NO144455C (tr) |
| SE (1) | SE7502298L (tr) |
| ZA (1) | ZA75894B (tr) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4035372A (en) * | 1976-08-13 | 1977-07-12 | G. D. Searle & Co. | 4-{[4-(Diphenylmethyl)-1-piperidinyl]methyl}benzenamines |
| US4163790A (en) * | 1977-05-11 | 1979-08-07 | A. H. Robins Company, Inc. | Method for increasing coronary blood flow in mammals |
| US4285958A (en) * | 1979-04-10 | 1981-08-25 | Richardson-Merrell Inc. | 1-Piperidine-alkylene ketones, pharmaceutical compositions thereof and method of use thereof |
| US4285957A (en) * | 1979-04-10 | 1981-08-25 | Richardson-Merrell Inc. | 1-Piperidine-alkanol derivatives, pharmaceutical compositions thereof, and method of use thereof |
| US4254130A (en) * | 1979-04-10 | 1981-03-03 | Richardson-Merrell Inc. | Piperidine derivatives |
| US4254129A (en) * | 1979-04-10 | 1981-03-03 | Richardson-Merrell Inc. | Piperidine derivatives |
| US4370335A (en) * | 1982-02-02 | 1983-01-25 | Mcneilab, Inc. | Antisecretory 4-diphenylmethyl-1-[(oxoalkyl)imino]methyl-piperidines and their derivatives |
| KR910006138B1 (ko) * | 1986-09-30 | 1991-08-16 | 에자이 가부시끼가이샤 | 환상아민 유도체 |
| DE3917241A1 (de) * | 1989-05-26 | 1990-11-29 | Schaper & Bruemmer Gmbh | 4-(hydroxydiphenylmethyl)-1-piperidyl-phenylalkan-derivate |
| US6087346A (en) * | 1993-06-23 | 2000-07-11 | Cambridge Neuroscience, Inc. | Sigma receptor ligands and the use thereof |
| WO1995000482A1 (en) * | 1993-06-24 | 1995-01-05 | Albany Molecular Research, Inc. | Piperidine derivatives and process for their production |
| US20020007068A1 (en) * | 1999-07-16 | 2002-01-17 | D'ambra Thomas E. | Piperidine derivatives and process for their production |
| US6147216A (en) * | 1993-06-25 | 2000-11-14 | Merrell Pharmaceuticals Inc. | Intermediates useful for the preparation of antihistaminic piperidine derivatives |
| CN1159277C (zh) | 1993-06-25 | 2004-07-28 | 默里尔药物公司 | 用于制备抗组胺哌啶衍生物的新中间体 |
| US6153754A (en) | 1995-12-21 | 2000-11-28 | Albany Molecular Research, Inc. | Process for production of piperidine derivatives |
| US6201124B1 (en) | 1995-12-21 | 2001-03-13 | Albany Molecular Research, Inc. | Process for production of piperidine derivatives |
| CA2330611A1 (en) | 1998-05-22 | 1999-12-02 | The Board Of Trustees Of The Leland Stanford Junior University | Bifunctional molecules and therapies based thereon |
| US6613907B2 (en) | 2000-11-08 | 2003-09-02 | Amr Technology, Inc. | Process for the production of piperidine derivatives with microorganisms |
| DE60234057D1 (de) | 2001-07-25 | 2009-11-26 | Raptor Pharmaceutical Inc | Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke |
| EP1560814A1 (en) * | 2002-11-13 | 2005-08-10 | Synthon B.V. | Process for making risperidone and intermediates therefor |
| EP1889198B1 (en) | 2005-04-28 | 2014-11-26 | Proteus Digital Health, Inc. | Pharma-informatics system |
| DK3395372T3 (da) | 2009-02-20 | 2022-04-19 | Enhanx Biopharm Inc | System til afgivelse af glutathion-baseret medikament |
| EP2427178B1 (en) | 2009-05-06 | 2023-01-04 | Laboratory Skin Care, Inc. | Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE794596A (fr) * | 1972-01-28 | 1973-05-16 | Richardson Merrell Inc | Piperidinoalcanone-oximes substituees et leur procede de preparation |
| US3806526A (en) * | 1972-01-28 | 1974-04-23 | Richardson Merrell Inc | 1-aroylalkyl-4-diphenylmethyl piperidines |
-
1974
- 1974-03-04 US US05/447,926 patent/US3946022A/en not_active Expired - Lifetime
-
1975
- 1975-02-07 GB GB538075A patent/GB1442118A/en not_active Expired
- 1975-02-11 IL IL46613A patent/IL46613A/xx unknown
- 1975-02-12 ZA ZA00750894A patent/ZA75894B/xx unknown
- 1975-02-12 IE IE275/75A patent/IE40598B1/xx unknown
- 1975-02-18 DE DE19752506770 patent/DE2506770A1/de not_active Withdrawn
- 1975-02-20 CA CA220,522A patent/CA1053678A/en not_active Expired
- 1975-02-24 NL NL7502157A patent/NL7502157A/xx not_active Application Discontinuation
- 1975-02-26 BE BE153769A patent/BE826012A/xx unknown
- 1975-02-28 SE SE7502298A patent/SE7502298L/xx unknown
- 1975-03-03 ES ES435246A patent/ES435246A1/es not_active Expired
- 1975-03-03 FR FR7506579A patent/FR2262986B1/fr not_active Expired
- 1975-03-03 JP JP50025119A patent/JPS50117780A/ja active Pending
- 1975-03-03 CH CH265775A patent/CH610888A5/xx not_active IP Right Cessation
- 1975-03-03 DK DK84375*#A patent/DK84375A/da not_active Application Discontinuation
- 1975-03-03 NO NO750698A patent/NO144455C/no unknown
-
1979
- 1979-09-20 DK DK393279A patent/DK393279A/da not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| GB1442118A (en) | 1976-07-07 |
| US3946022A (en) | 1976-03-23 |
| ZA75894B (en) | 1976-01-28 |
| BE826012A (fr) | 1975-06-16 |
| DK393279A (da) | 1979-09-20 |
| CH610888A5 (tr) | 1979-05-15 |
| FR2262986B1 (tr) | 1980-02-22 |
| DE2506770A1 (de) | 1975-09-11 |
| IE40598B1 (en) | 1979-07-04 |
| NO144455B (no) | 1981-05-25 |
| CA1053678A (en) | 1979-05-01 |
| SE7502298L (tr) | 1975-09-05 |
| ES435246A1 (es) | 1976-12-16 |
| AU7808475A (en) | 1976-08-12 |
| IL46613A0 (en) | 1975-04-25 |
| IL46613A (en) | 1979-09-30 |
| JPS50117780A (tr) | 1975-09-16 |
| NL7502157A (nl) | 1975-09-08 |
| FR2262986A1 (tr) | 1975-10-03 |
| IE40598L (en) | 1975-09-04 |
| DK84375A (tr) | 1975-09-05 |
| NO750698L (tr) | 1975-09-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO144455C (no) | Fremgangsmaate ved fremstilling av terapeutisk aktive nye piperidinderivater. | |
| NO154521C (no) | Analogifremgangsmaate for fremstilling av nye, terapeutisk aktive piperidinderivater. | |
| NO141407C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive etylenderivater | |
| NO145382C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive 3-amino-indazolkarboksylsyrederivater. | |
| NO143219C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive forbindelser. | |
| NO143460C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzomorfaner. | |
| NO141800C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzomorfaner. | |
| NO146909C (no) | Fremgangsmaate til fremstilling av terapeutisk virksomme pyrrolidinderivater. | |
| NO142865C (no) | Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive karbazoler | |
| NO143223C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive 1,3-dimetyl-1h-pyrazol(3,4b)kinoliner | |
| NO142838C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive isokinolinderivater | |
| NO141850C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive pyrazolderivater. | |
| NO143064C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive hydroksyalkylxantiner | |
| SE431207B (sv) | Forfarande for framstellning av tiazolidinderivat | |
| NO144108C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive n-(1-benzylpiperid-4-yl)-benzamider | |
| NO146497C (no) | Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive 2-anilino-oxazoliner | |
| NO144457C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive dihydro-1,4-pyridiner | |
| NO142077C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive n-(1-cyclohexyl-3-pyrrolidinyl)-benzamider | |
| NO145383C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte indoler. | |
| NO147485C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 8-aminomethylisoflavonderivater | |
| NO144110C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 5:6-benzo-4-pyron-derivater | |
| NO145620C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive depotsteroidestere. | |
| NO145238C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive dihydrokarbostyril-derivater | |
| NO146672C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive cinnolinderivater | |
| NO142403C (no) | Analogifremgangsmaate for fremstilling av farmakologisk aktive isokinoliner. |